New insights into tumor-host interactions in lymphoma metastasis

Journal of Molecular Medicine

Volumn 74, Issue 7, 1996, Pages 353-363

  Umansky, V ^a   Schirrmacher, V ^a   Rocha, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Costimulatory and adhesion molecules; Metastasis; Nitric oxide; Tumor microenvironment

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NITRIC OXIDE; VASCULAR CELL ADHESION MOLECULE 1;

CANCER INVASION; CELL INTERACTION; GROWTH REGULATION; HOST CELL; HUMAN; IMMUNOREGULATION; LYMPHOMA; METASTASIS POTENTIAL; PATHOPHYSIOLOGY; REVIEW; TUMOR CELL; TUMOR GROWTH;

EID: 0029784242     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00210630     Document Type: Review

References (122)

1. Weiss L (1985) Principles of metastasis. Academic, Orlando
2. Fidler IJ, Balch KI (1987) The biology of cancer metastasis and implications for therapy. Curr Probl Surg 24:131-209
3. Nicolson GL (1993) Cancer progression and growth: relationship of paracrine and automne growth mechanisms to organ preference of metastasis. Exp Cell Res 204:171-180
4. Mareel MM, Van Roy FM, Bracke ME (1993) How and when do tumor cells metastasize? Crit Rev Oncogenesis 4:559-594
5. Price JE (1994) Host-tumor interactions in the progression of breast cancer metastasis. In Vivo 8:145-154
6. Nicolson GL (1989) Organ specificity of tumor metastasis: role of preferential adhesion, invasion, and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7:143-188
7. Fidler IJ (1990) Host and tumour factors in cancer metastasis. Eur J Clin Invest 20:481-486
8. Whiteside TL, Herberman RB (1992) Extravasation of antitumor effector cells. Invasion Metastasis 12:128-146
9. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571-573
10. Schirrmacher V (1992) Immunity and metastasis: In situ activation of protective T-cells by virus modified cancer vaccines. Cancer Surv 13:129-154
11. Den Otter W (1986) Immune surveillance and natural resistance: an evaluation. Cancer Immunol Immunother 21:85-92
12. Whitworth PW, Pak CC, Esgro J, Kleinerman ES, Fidler IJ (1990) Macrophages and cancer. Cancer Metastasis Rev 8: 319-351
13. Belloni PN, Tressler RJ (1990) Microvascular endothelial cell heterogeneity: interactions with leucocytes and tumor cells. Cancer Metastasis Rev 8:353-389
14. Miller FR (1993) Immune mechanisms in the sequential steps of metastasis. Crit Rev Oncogenesis 4:293-311
15. Rosenberg SA (1991) Immunotherapy and gene therapy of cancer. Cancer Res 51:5074-5079
16. Fidler IJ (1991) Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 10: 229-243
17. Radinsky R, Fidler IJ (1992) Regulation of tumor cell growth at organ-specific metastases. In Vivo 6:325-331
18. Pallesen G, Hamilton-Dutoit SJ, Zhou X (1993) The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two developments in the EBV field. Adv Cancer Res 62:179-239
19. Armitage JO (1993) Treatment of non-Hodgkin's lymphoma. N Engl J Med 328:1023-1030
20. Rudders R, Levin A, Jespersen D, Zacks J, Delellis R, Ranger A, Kronitis T (1992) Crossreacting human lymphoma idiotypes. Blood 80:1039-1044
21. Benke R, Lang E, Komitowski D, Muto S, Schirrmacher V (1988) Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth. Invasion Metastasis 8:159-176
22. Schackert G, Fidler IJ (1988) Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals. Cancer Res 48:3478-3484
23. Krüger A, Schirrmacher V, von Hoegen P (1994) Scattered micrometastasis visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58:275-284
24. Lampson LA, Lampson MA, Dunne AD (1993) Exploiting the lacZ reporter gene for quantitative analysis of disseminated tumor growth within the brain: use of the lacZ gene product as a tumor antigen, for evaluation of antigenic modulation, and to facilitate image analysis of tumor growth in situ. Cancer Res 53:176-182
25. Dooley TP, Stamp-Cole M, Ouding RJ (1993) Evaluation of a nude mouse tumor model using β-galactosidase-expressing melanoma cells. Lab Anim Sci 43:48-57
26. Kurebayashi J, MsLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG (1993) Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res 53:2178-2187
27. Schirrmacher V, Beckhove P, Krüger A, Rocha M, Umansky V, Fichtner KP, Hull WE, Zangemeister-Wittke U, Griesbach A, Jurianz K, von Hoegen P (1995) Effective immune rejection of advanced metastasized cancer. Int J Oncol 6:505-521
28. Schirrmacher V, Schild HJ, Gückel B, von Hoegen P (1992) Tumor specific CTL response requiring interactions of four different cell types and dual recognition of MHC class I and class II restricted tumor antigens. Immunol Cell Biol 71: 311-326
29. Schirrmacher V, Zangemeister-Wittke U (1994) γ-Irradiation suppresses T cell mediated protective immunity against a metastatic tumor in the afferent phase of the immune response but enhances it in the efferent phase when given before immune cell transfer. Int J Oncol 4:335-346
30. + helper T cells are required for resistance to a highly metastatic murine tumour. Eur J Immunol 17:1863-1866
31. Gückel B, Berek C, Lutz M, Altevogt P, Schirrmacher V, Kyewski B (1991) Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med 174:957-967
32. Schirrmacher V, Leidig S, Griesbaeh A (1991) In situ activation of syngeneic tumour-specific cytotoxic T lymphocytes: intra-pinna immunization followed by restimulation in the peritoneal cavity. Cancer Immunol Immunother 33:299-306
33. Krüger A, Umansky V, Rocha M, Hacker HJ, Schirrmacher V, von Hoegen P (1994) Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 84:3166-3174
34. Rocha M, Krüger A, Umansky V, von Hoegen P, Naor D, Schirrmacher V (1996) Dynamic expression-changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasis. Clin Cancer Res (in press)
35. Plautz GE, Yang ZY, Wu BY, Gao X, Huang L, Nabel GJ (1994) Immunotherapy of malignancy by in vivo transfer into tumors. Proc Natl Acad Sci USA 90:4645-4649
36. Schirrmacher V, Fogel M, Russmann E, Bosslet K, Altevogt P, Beck L (1982) Antigenic variation in cancer metastasis: immune escape versus immune control. Cancer Met Rev 1: 241-274
37. Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJ, Walboomers JM (1994) Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179:335-340
38. Guardiola J, Maffei A (1993) Control of MHC class II gene expression in autoimmune, infectious and neoplastic disease. Crit Rev Immunol 13:247-268
39. Janeway CA Jr, Bottomly K (1994) Signals and signs for lymphocyte responses. Cell 76:275-285
40. Azuma M, Yssel H, Phillips JJ, Spits H, Lanier LL (1993) Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 177:845-850
41. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGovan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093-1098
42. Chen L, Linsley PS, Hellstrom KE (1993) Costimulation of T cells for tumor immunity. Immunol Today 14:483-486
43. Towsend SE, Allison JP (1993) Tumor rejection after direct Costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259:368-371
44. Baskar S, Nabavi N, Glimcher LH, Rosenberg S (1993) Tumor cells expressing major histocompatibility complex class II and B7 activation molecules stimulate potent tumor-specific immunity. J Immunother 14:209-215
45. + melanoma. Int Immunol 5:1501-1508
46. Graf L, Koch N, Schirrmacher V (1985) Expression of Ia antigens in a murine T-lymphoma variant. Mol Immunol 22: 1371-1377
47. Semino C, Ferlazzo G, Pietra G, Pasquetti W, Repetto L, Rosso R, Mariani M, Melioli G (1993) Heterogeneity of the alpha-interferon mediated overexpression of class I and class II major histocompatibility complex molecules in primary cultured cancer cells. J. Biol Regul Homeost Agents 7:99-104
48. Crocker PR, Gordon S (1986) Properties and distribution of a lectin-like hemagglutinin differentially expressed by stromal tissue macropages. J Exp Med 164:1862-1875
49. Crocker PR, Gordon S (1989) Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med 169:1333-1346
50. Crocker PR, Kelm S, Dubois C, Martin B, McWilliam AS, Shotton D, Paulson JC, Gordon S (1991) Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J 10:1661-1669
51. Crocker PR, Mucklow S, Bouckson V, McWilliam A, Willis AC, Gordon S, Milon G, Kelm S, Bradfield P (1994) Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO J 13:4490-4503
52. Van den Berg TK, Breve JJP, Damoiseaux JGMC, Döpp EA, Kelm S, Crocker PR, Dijkstra CD, Kraal G (1992) Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J Exp Med 176:647-655
53. Umansky V, Beckhove P, Rocha M, Krüger A, Crocker PR, Schirrmacher V (1996) A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo. Immunology 87:303-309
54. Damoiseaux JGMC, Döpp EA, Beelen RHJ, Dijkstra CD (1989) Rat bone marrow and monocyte cultures: influence of culture time and lymphokines on the expression of macrophage differentiation antigens. J. Leukocyte Biol 46:246-253
55. Damoiseaux JGMC, Huitinga I, Döpp EA, Dijkstra CD (1992) Expression of the ED3 antigen on rat macrophages in relation to experimental autoimmune diseases. Immunobiology 184:311-320
56. Crocker PR, Hill M, Gordon S (1988) Regulation of a murine macrophage haemagglutinin (sheep erythrocyte receptor) by a species-restricted serum factor. Immunology 65:515-522
57. McWilliam AS, Tree P, Gordon S (1992) Interleukin 4 regulates induction of sialoadhesin, the macrophage sialic acid-specific receptor. Proc Natl Acad Sci USA 89:10522-10526
58. Doyle AG, Herbein G, Montaner L, Minty AJ, Caput D, Ferrara P, Gordon S (1994) Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur J Immunol 24, 1441-1445
59. Klein T, Döffinger R, Pepis MB, Rüther U, Kyewski B (1995) Tolerance and immunity to the inducible self antigen C-reactive protein in transgenic mice. Eur J Immunol 25:3489-3495
60. Albelda SM (1993) Biology of disease. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 68:4-17
61. Roos E, Roosien FF (1987) Involvement of leucocyte function-asocciated antigen-1 (LFA-1) in the invasion of hepatocyte cultures by lymphoma and T-cell hybridoma cells. J Cell Biol 105:553-557
62. Grander B, Wang P, Einhorn S (1994) Gamma-IFN induced cell adhesion in chronic myelogenous leukemia cells. Leukemia 8:299-304
63. Stauder R, Greil R, Schulz TF, Gattringer C, Radaskiewicz T, Dierich MP, Huber H (1989) Expression of leucocyte function-associated antigen-1 and 7F7 antigen, an adhesion molecule related to intercellular adhesion molecules-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence of growth and leukaemic behaviour. Clin Exp Immunol 77:234-238
64. Harning R, Myers C, Merluzzi VJ (1993) Monoclonal antibodies to lymphocyte function-associated antigen-1 inhibit invasion of human lymphoma and metastasis of murine lymphoma. Clin Exp Metast 11:337-342
65. Zahalka MA, Ökon E, Naor D (1993) Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leucocyte adhesion molecule (CD18). J Immunol 150:4466-4477
66. Clayberger C, Wright A, Medeiros LJ, Koller TD, Link MP, Smith SD, Warnke RA, Krensky AM (1987) Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet II:533-536
67. Koyama S, Ebihara T, Fukao K (1992) Expression of intercellular adhesion molecule-1 (ICAM-1) during development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol 118:609-614
68. Dolcetti R, Maestro R, Gasparotto D, Rizzo S, Boiocchi M (1992) Adhesion molecule expression does not influence the leukemic behaviour of murine T-cell lymphomas. Leukemia 6:101S-105S
69. Johnson JP, Stade BG, Holzman B, Schwable W, Riethmuller G (1989) De novo expression of intercellular adhesion molecule in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86:641-644
70. Schirren CA, Volpel H, Hoffmann JC, Henning SW, Qiao L, Autschbach F, Dengler TJ, Dohner H, Meuer SC (1992) Biological response modifiers render tumor cells susceptible to autologous effector mechanisms by influencing adhesion receptors. Leuk Lymphoma 10:25-33
71. Gonzalez-Amaro R, Garcia-Monzon C, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yague E, Pivel JP, Lopez Cabrera M, Fernandez Ruiz E (1994) Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 179:841-848
72. Jurianz K (1995) Molekulare Analyse der Induktion tumor-spezifische Immunantworten: Vergleich von Tumor-resistenz und Suszeptibilität in einem Maus Tumor Modellsystem. PhD Thesis, University of Heidelberg
73. Dustin ML, Staunton DE, Springer TA (1988) Supergene families meet in the immune system. Immunol Today 9: 213-215
74. Kim SJ, Kim NS, Lee JL (1993) Effect of cytokines on the expression of cell adhesion molecules and on the adhesion of melanoma cells to endothelial cells. J Korean Med Sci 8:41-52
75. Grander B, Wang P, Einhorn S (1994) Gamma-IFN induced cell adhesion in chronic myelogenous leukemia cells. Leukemia 8:299-304
76. Hansen AB, Bouchelouche PN, Lillevang ST, Andersen CB (1994) Interferon-gamma increases cellular calcium ion concentration and inositol 1,4,5-trisphosphate formation in human renal carcinoma cells: relation to ICAM-1 antigen expression. Br J Cancer 69:291-298
77. Hutchins D, Steel M (1994) Regulation of ICAM-1 (CD54) expression in human breast cancer lines by interleukin 6 and fibroblast-derived factors. Int J Cancer 58:80-84
78. Swerlick RA, Lawley TJ (1993) Role of microvascular endothelial cells in inflammation. J Invest Dermatol 100: 111S-115S
79. Antonia SJJ, Uchida S, Cohen S, Cohen MC (1989) Attachment of tumor cells to endothelial monolayers: detection of surface molecules involved in cell-binding. Clin Immunol Immunopathol 53:281-285
80. Rice GE, Beviclaqua MP (1989) An inducible endothelial surface glycoprotein mediates melanoma adhesion. Science 246:1303-1306
81. Hemler ME, Elices MJ, Parker C, Takada Y (1990) Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 114:45-65
82. Freedmann AS, Saporito L, Rhynhart K, Morimoto C, Nadler LM (1994) Adhesion of follicular lymphoid germinal centers: a potential mechanism of tumor cell homing following autologous transplantation. Leuk Lymphoma 13:47-52
83. Van Riet I, Van Camp B (1993) The involvement of adhesion molecules in the biology of multiple myeloma. Leuk Lymphoma 9:441-452
84. Juneja HS, Schmalsteig FC, Lee S, Chen J (1993) Vascular cell adhesion molecule-1 and VLA-4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells. Exp Hematol 21:444-450
85. 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 77:335-347
86. Okahara H, Yagita H, Miyake K, Okumura K (1994) Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molcule (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res 54: 3233-3236
87. Garofalo A, Chiviri RGS, Foglieni C, Pigott R, Mortarini R, Martin-Padura I, Anichini A, Gearing AI, Sanchez-Madrid F, Dejana E, Giavazzi, R (1995) Involvement of very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastasis. Cancer Res 55:414-419
88. Rocha M, Umansky V, Schirrmacher V, Elices MJ (1996) In situ downregulation of VLA-4 integrin cell surface expression during lymphoma growth and liver metastasis. (submitted)
89. Bouwens L, Baekeland M, Wisse E (1984) Importance of local proliferation in the expanding Kupffer cell population of rat liver after zymosan stimulation and partial hepatectomy. Hepatology 4:213-219
90. Phillips NC (1989) Kupffer cells and liver metastases. Optimization and limitation of activation of tumoricidal activity. Cancer Metastasis Rev 8:231-252
91. Zhang W, Arii S, Sassaoki T, Adachi Y, Funaki N, Higashitsuji H, Fujita S, Furutani M, Mise M, Ishiguro S (1993) The role of Kupffer cells in the surveillance of tumor growth in the liver. J Surg Res 55:140-146
92. McCuskey PA, Kan Z, Wallace S (1994) An electron microscopy study of Kupffer cells in livers of mice having Friend erythroleukemia hepatic metastases. Clin Exp Metastasis 12: 416-426
93. Kan Z, Ivancev K, Lunderquist A, McCuskey PA, McCuskey RS, Wallace S (1995) In vivo microscopy of hepatic metastases: dynamic observation of tumor cell invasion and interaction with Kupffer cells. Hepatology 21:487-494
94. Heuff G, Oldenburg HSA, Boutkan H, Visser JJ, Beelen RHJ, Van Rooijen N, Dijkstra CD, Meyer S (1993) Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother 37:125-130
95. Hibbs JB, Taintor R, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87-94
96. Stuehr DJ, Nathan CF (1989) Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543-1555
97. Moncada S, Palmer RJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-134
98. Marietta MA, Yoon PS, Lyengar R, Leaf CD, Wishnok JS (1988) Macrophage oxidation of -arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706-8711
99. Kwon NS, Stuehr DJ, Nathan CF (1991) Inhibition of tumor cell ribonucleotide ribonuclease by macrophage-derived nitric oxide. J Exp Med 174:761-767
100. Umansky V, Rocha M, Krüger A, von Hoegen P, Schirrmacher V (1995) In situ activated macrophages are involved in host resistance to lymphoma metastasis by production of nitric oxide. Int J Oncol 7:33-40
101. Fidler IJ, Schroit AJ (1988) Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochem Biophys Acta 948:151-174
102. Takeshita M, Sumiyoshi Y, Masuda Y, Ohshima K, Yoshida T, Kikuchi M, Muller H (1993) Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6) possessing in lymph nodes of malignant lymphoma. Pathol Res Pract 189:18-25
103. Aono K, Isobe K, Nakashima I, Kondo S, Miyachi M, Nimura Y (1994) Kupffer cells cytotoxicity against hepatoma cells is related to nitric oxide. Biochem Biophys Res Commun 201:1175-1181
104. Kurose I, Miura S, Fukumura D, Yonei Y, Saito H, Tada S, Suematsu M, Tsuchiya M (1993) Nitric oxide mediates Kupffer cell-induced reduction of mitochondrial energization in hepatoma cells. A comparison with oxidative burst. Cancer Res 53:2676-2682
105. Karnovsky ML, Lazdins JK (1978) Biochemical criteria for activated macrophages. J Immunol 121:809-813
106. Xie K, Huang S, Dong Z, Gutman M, Fidler IJ (1995) Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 55:3123-3131
107. Senger DR, Perruzzi CA, Gracey CF, Papadopoulos A, Tenen DG (1988) Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 48:5770-5774
108. Denhardt DT, Chambers AF (1994) Overcoming obstacles to metastasis-defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 56:1-4
109. Feng B, Rollo EE, Denhardt DT (1995) Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines downregulated for OPN expression by a targeted ribozyme. Clin Exp Met 13:453-462
110. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Scince 271:509-512
111. Schirrmacher V, Fogel M, Russmann E, Bosslet K, Altevogt P, Beck L (1982) Antigenic variation in cancer metastasis: Immune escape versus immune control. Cancer Met Rev 1: 241-274
112. Von Hoegen P, Weber E and Schirrmacher V (1986) Modification of tumor cells by a low dose of Newcastle disease virus. I. Augmentation of the tumor-specific T cell response in the absence of an antiviral response. Eur J Immunol 18: 1159-1164
113. Schirrmacher V (1989) Immunobiology and immunotherapy of cancer metastases. Interdise Sci Rev 14:291-303
114. Thorbecke GJ, Silberberg-Sinakin I, Flotte TJ (1980) Langerhans cells as macrophages in skin and lymphoid organs. J Invest Dermatol 75:32-43
115. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526
116. Li L, Kilbourn RG, Adams J, Fidler IJ (1991) Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51:2531-2535
117. Li L, Nicolson GL, Fidler IJ (1991) Direct in vitro lysis of metastatic tumor cells by cytokine-activated murine vascular endothelial cells. Cancer Res 51:245-254
118. Rocha M, Krüger A, van Rooijen N, Schirrmacher V, Umansky V (1995) Liver endothelial cells participate in T cell dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo. Int J Cancer 63:405-411
119. Estrada C, Gomez C, Martin C, Moncada S, Gonzalez C (1992) Nitric oxide medites tumor necrois factor-alpha cytotoxicity in endothelial cells. Biochem Biophys Res Commun 186:475-82
120. Van Roojien N, Sanders AM (1994) Liposome mediated depletion of macrophages: mechansim of action, preparation of liposomes and applications. J Immunol Method 174:83-93
121. Bogers WMJM, Stadt RK, Jansenn DJ, Van Rooijen N, Van Es LA, Dajha MR (1991) Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells. Clin Exp Immunol 86:328-333
122. Radinsky R, Beltran PJ, Tsan R, Zhang R, Cone RD, Fidler IJ (1995) Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma. Cancer Res 55:141-148